Alex Martin del Campo

Alex Martin del Campo

Knobbe Martens

Contact
View Bio
RSS

Latest Posts › Pharmaceutical Patents

Share:

Litigation Update | July 2025

JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. - Before Prost, Reyna, and Taranto. Appeal from the United States District Court for the District of New Jersey. The Federal Circuit found that claims reciting a...more

8/8/2025  /  Appeals , Design Patent , Doctrine of Equivalents , Intellectual Property Litigation , Obviousness , Patent Infringement , Pharmaceutical Industry , Pharmaceutical Patents , Prescription Drugs , Prosecution History Estoppel

Combination Dosing Regimen Not Obvious Despite Overlapping Prior-Art Ranges

JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. Before Prost, Reyna, and Taranto. Appeal from the United States District Court for the District of New Jersey. The Federal Circuit found that claims reciting a...more

7/28/2025  /  Appeals , Generic Drugs , Obviousness , Patent Invalidity , Patent Litigation , Patents , Pharmaceutical Patents , Prior Art , Teva Pharmaceuticals
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide